P

Inventor

CHOI SEOK-KI

US77 patents
⚠️ This page may combine multiple inventors who share the name “CHOI SEOK-KI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

THERAVANCE INC

37 patents
US6576793B1Jun 10, 2003

β2-adrenergic receptor agonists

THERAVANCE INC115 citations99
US6541669B1Apr 1, 2003

β2-adrenergic receptor agonists

THERAVANCE INC114 citations99
US7879896B2Feb 1, 2011

Dual-acting imidazole antihypertensive agents

THERAVANCE INC53 citations98
US8013005B2Sep 6, 2011

Dual-acting antihypertensive agents

THERAVANCE INC42 citations96
US7375114B2May 20, 2008

Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

THERAVANCE INC41 citations96
US6713651B1Mar 30, 2004

β2-adrenergic receptor agonists

THERAVANCE INC49 citations96
US6593497B1Jul 15, 2003

β2-adrenergic receptor agonists

THERAVANCE INC56 citations96
US8377964B2Feb 19, 2013

Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

THERAVANCE INC10 citations93
US7759363B2Jul 20, 2010

Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists

THERAVANCE INC18 citations93
US7317022B2Jan 8, 2008

Benzoimidazolone-carboxamide compounds as 5-HT4 receptors agonists

THERAVANCE INC19 citations93
US6919482B2Jul 19, 2005

β2-adrenergic receptor agonists

THERAVANCE INC13 citations93
US7989484B2Aug 2, 2011

Dual-acting antihypertensive agents

THERAVANCE INC25 citations92
US7863309B2Jan 4, 2011

Dual-acting antihypertensive agents

THERAVANCE INC27 citations92
US7834041B2Nov 16, 2010

Dual-acting antihypertensive agents

THERAVANCE INC29 citations92
US7763637B2Jul 27, 2010

Quinolinone-carboxamide compounds as 5-HT4, receptor agonists

THERAVANCE INC12 citations92
US7419989B2Sep 2, 2008

Indazole-carboxamide compounds

THERAVANCE INC19 citations92
US7399862B2Jul 15, 2008

5-HT4 receptor agonist compounds

THERAVANCE INC26 citations92
US7396933B2Jul 8, 2008

Quinolinone-carboxamide compounds

THERAVANCE INC28 citations92
US7351704B2Apr 1, 2008

Indazole-carboxamide compounds as 5-HT4 receptor agonists

THERAVANCE INC25 citations92
US7183323B2Feb 27, 2007

Sodium channel modulators

THERAVANCE INC20 citations92
US6756400B2Jun 29, 2004

Sodium channel modulators

THERAVANCE INC36 citations92
US6646012B2Nov 11, 2003

Sodium channel modulators

THERAVANCE INC30 citations92
US6479498B1Nov 12, 2002

Sodium channel drugs and uses

THERAVANCE INC36 citations92
US7777077B2Aug 17, 2010

Dual-acting antihypertensive agents

THERAVANCE INC34 citations91
US7534889B2May 19, 2009

5-HT4 receptor agonist compounds

THERAVANCE INC13 citations84
US7498442B2Mar 3, 2009

Quinolinone-carboxamide compounds

THERAVANCE INC10 citations84
US7446114B2Nov 4, 2008

Quinolinone compounds as 5-HT4 receptor agonists

THERAVANCE INC10 citations84
US6683115B2Jan 27, 2004

β2-adrenergic receptor agonists

THERAVANCE INC16 citations84
US8344013B2Jan 1, 2013

Dual-acting imidazole antihypertensive agents

THERAVANCE INC4 citations74
US7875629B2Jan 25, 2011

Quinolinone compounds as 5-HT4 receptor agonists

THERAVANCE INC6 citations74
US7217738B2May 15, 2007

β2-adrenergic receptor agonists

THERAVANCE INC6 citations74
US8349875B2Jan 8, 2013

Dual-acting antihypertensive agents

THERAVANCE INC3 citations73
US7226950B2Jun 5, 2007

Sodium channel modulators

THERAVANCE INC7 citations73
US6872741B2Mar 29, 2005

Sodium channel modulators

THERAVANCE INC7 citations73
US7772239B2Aug 10, 2010

Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonists

THERAVANCE INC4 citations63
US7329752B2Feb 12, 2008

Carbamate compounds as 5-HT4 receptor agonists

THERAVANCE INC4 citations63
US7105701B2Sep 12, 2006

β2-adrenergic receptor agonists

THERAVANCE INC2 citations63

ALLEGRETTI PAUL

4 patents

ADVANCED MEDICINE INC

3 patents

CHOI SEOK-KI

3 patents

THERAVANCE BIOPHARMA R&D IP LLC

2 patents

MARQUESS DANIEL

1 patent

Showing the top 50 of 77 patents by PatentIndex Score.